Stocks | | |
Finding good stocks to buy in the market these days is no easy task. Although stocks have rebounded nicely off of the March lows, many investors are having trouble figuring out why. Some even believe that we have never seen such a large disconnect between equity valuations and fundamentals. Even b... Read the Full Story |
|
From Our PartnersMillionaire trader Tim Sykes will show you a brand-new way of making $1,000s in a matter of minutes… as soon as the market opens.
He’s made $1,150… $1,672… and even $3,508… all in less than 30 minutes.
It’s all thanks to a strange phenomenon that happens when the market opens at 9:30 AM… something Sykes calls “a morning panic.”
Simply buy shares when the panic is over…And cash out with potentially $1,000s in a matter of minutes…
| | Learn How At Tim's Profit Summit (FREE Event) |
|
Markets | | |
Of all the stocks that should be on top of the world right now, a stock that pretty much encourages people to never touch currency or each other should be pretty close. You'd think so, anyway, but as far as PayPal (NASDAQ: PYPL) is concerned, it just took a serious step downward. BMO Capital Marke... Read the Full Story |
|
Markets | | | It's been amazing to witness the way that technology has changed how businesses operate over the last decade.Twilio Inc (NYSE:TWLO) is a cloud communications platform that essentially helps companies add voice, messaging, and video capabilities Read the Full Story |
|
Markets | | |
Brookfield Asset Management (NYSE:BAM) stock is down 20% in 2020. The stock is trying to find direction after the company reported first-quarter earnings per share of negative 20 cents. That was well below analysts’ expectations for 48 cents per share.
On first glance, it may be understanda... Read the Full Story |
|
Markets | | | A King By Any Other Name Would Be As Stable
In recent weeks I have found myself turning up more and more Dividend Aristocrats and Dividend Kings in my search for opportune investments. Time and time again, when these stocks intersect with secular trends, pandemic-related stockpiling, remote-working... Read the Full Story |
|
|
The Early Bird Stock Of The Day VBI Vaccines Inc., a commercial-stage biopharmaceutical company, develops and sells vaccines to treat immuno-oncology and infectious disease. It offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. The company also develops VBI-2601, a protein based immunotherapeutic candidate for the treatment of chronic HBV infection; VBI-1901, a glioblastoma vaccine immunotherapeutic candidate, which is in Phase I/IIa clinical study to treat solid tumors; VBI-1501, a prophylactic cytomegalovirus vaccine candidate that has completed Phase I clinical trial; and VBI-2501 that is in preclinical trial to treat Zika virus. In addition, it develops coronavirus vaccine candidates that include VBI-2902, VBI-2901, and VBI-2905. The company has collaboration and license agreements with Brii Biosciences Limited; and the National Research Council of Canada to develop pan-coronavirus vaccine candidate targeting COVID-19, severe acute respiratory syndrome, and Middle East respiratory syndrome. The company was formerly known as SciVac Therapeutics Inc. and changed its name to VBI Vaccines Inc. in May 2016. VBI Vaccines Inc. is based in Cambridge, Massachusetts. | | View Today's Stock Pick |
|
